MARGINAL ZONE LYMPHOMA
Clinical trials for MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis study tests an experimental drug called nemtabrutinib (ARQ 531) in about 190 adults with certain blood cancers (like lymphoma or leukemia) that returned or didn't respond to prior therapy. The goal is to check the drug's safety and how well it works. Participants take the dr…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New immunotherapy cocktail aims to tackle lymphoma without chemo
Disease control OngoingThis study tests whether combining two immunotherapy drugs, glofitamab and obinutuzumab, can safely and effectively treat people newly diagnosed with follicular lymphoma or marginal zone lymphoma. About 47 participants who have not had prior treatment will receive the drug combin…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC